will medicare pay for semaglutide for weight loss to Cover Weight-Loss Drug Wegovy Certain Patients Medicare Is Now Covering Some
Description
$30B/yr - Novo's GLP-1 revenue for weight-loss & diabetes now beginning to become exposed to generic options
If you're searching for weight loss solutions similar to Wegovy, multiple GLP-1 receptor agonist options exist today
Semaglutide, Tirzepatide & Synergy
Your workforce likely has a growing interest (or curiosity) in GLP-1 medications
Ozempic's active ingredient, semaglutide, reduces blood sugar levels and promotes weight loss
GLP-1 receptor agonists are designed for weight management, not thyroid treatment
